Table 2.
Treatment results
| Results | LD | SD |
|---|---|---|
| Intention-to-treat | ||
| No. of patients | 30 | 27 |
| SVR | 19 (63%) | 21 (78%) |
| Relapse/Breakthrough | 7 (23%) | 2 (7%) |
| Non-response | 3 (10%) | 1 (4%) |
| Treatment stopped for adverse event | 0 (0%) | 3 (11%) |
| Lost to follow-up | 1 (3%) | 0 (0%) |
| Per protocola | ||
| No. of patients | 28 | 23 |
| SVR | 19 (68%) | 20 (87%) |
| Relapse/Breakthrough | 7 (25%) | 2 (9%) |
| Non-response | 2 (7%) | 1 (4%) |
a
Excluded from analysis:
LD – 1 patient needed peginterferon dose reduction for neutropenia, 1 patient lost to follow-up
SD – 1 patient needed peginterferon dose reduction for neutropenia, 3 patients withdrawn from treatment for serious adverse events